Merck & Co., Inc.
Merck & Co., Inc. MRK Peers
See (MRK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MRK | $77.66 | -0.78% | 195B | 11.29 | $6.88 | +4.07% |
| LLY | $765.91 | +0.01% | 725.9B | 62.22 | $12.31 | +0.73% |
| AZN | $72.35 | -0.89% | 448.6B | 29.17 | $2.48 | +2.13% |
| JNJ | $153.67 | +0.29% | 369.7B | 17.09 | $8.99 | +3.26% |
| ABBV | $187.40 | +0.03% | 331B | 80.09 | $2.34 | +3.39% |
| NVO | $72.59 | +0.76% | 325.6B | 20.33 | $3.57 | +2.22% |
| NVS | $117.80 | +0.74% | 232.7B | 18.46 | $6.38 | +3.39% |
| AMGN | $287.10 | +0.03% | 154.4B | 26.17 | $10.97 | +3.20% |
| GILD | $110.45 | +1.31% | 137.4B | 14.27 | $7.74 | +2.80% |
| PFE | $23.11 | -1.20% | 131.4B | 16.75 | $1.38 | +7.35% |
Stock Comparison
MRK vs LLY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, LLY has a market cap of 725.9B. Regarding current trading prices, MRK is priced at $77.66, while LLY trades at $765.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas LLY's P/E ratio is 62.22. In terms of profitability, MRK's ROE is +0.38%, compared to LLY's ROE of +0.77%. Regarding short-term risk, MRK is less volatile compared to LLY. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs AZN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, AZN has a market cap of 448.6B. Regarding current trading prices, MRK is priced at $77.66, while AZN trades at $72.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas AZN's P/E ratio is 29.17. In terms of profitability, MRK's ROE is +0.38%, compared to AZN's ROE of +0.19%. Regarding short-term risk, MRK is more volatile compared to AZN. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs JNJ Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, JNJ has a market cap of 369.7B. Regarding current trading prices, MRK is priced at $77.66, while JNJ trades at $153.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas JNJ's P/E ratio is 17.09. In terms of profitability, MRK's ROE is +0.38%, compared to JNJ's ROE of +0.30%. Regarding short-term risk, MRK is more volatile compared to JNJ. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs ABBV Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, ABBV has a market cap of 331B. Regarding current trading prices, MRK is priced at $77.66, while ABBV trades at $187.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas ABBV's P/E ratio is 80.09. In terms of profitability, MRK's ROE is +0.38%, compared to ABBV's ROE of +0.96%. Regarding short-term risk, MRK is less volatile compared to ABBV. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs NVO Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, NVO has a market cap of 325.6B. Regarding current trading prices, MRK is priced at $77.66, while NVO trades at $72.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas NVO's P/E ratio is 20.33. In terms of profitability, MRK's ROE is +0.38%, compared to NVO's ROE of +0.81%. Regarding short-term risk, MRK is less volatile compared to NVO. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs NVS Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, NVS has a market cap of 232.7B. Regarding current trading prices, MRK is priced at $77.66, while NVS trades at $117.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas NVS's P/E ratio is 18.46. In terms of profitability, MRK's ROE is +0.38%, compared to NVS's ROE of +0.31%. Regarding short-term risk, MRK is more volatile compared to NVS. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs AMGN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, AMGN has a market cap of 154.4B. Regarding current trading prices, MRK is priced at $77.66, while AMGN trades at $287.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas AMGN's P/E ratio is 26.17. In terms of profitability, MRK's ROE is +0.38%, compared to AMGN's ROE of +0.93%. Regarding short-term risk, MRK is less volatile compared to AMGN. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs GILD Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, GILD has a market cap of 137.4B. Regarding current trading prices, MRK is priced at $77.66, while GILD trades at $110.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas GILD's P/E ratio is 14.27. In terms of profitability, MRK's ROE is +0.38%, compared to GILD's ROE of +0.32%. Regarding short-term risk, MRK is less volatile compared to GILD. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs PFE Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, PFE has a market cap of 131.4B. Regarding current trading prices, MRK is priced at $77.66, while PFE trades at $23.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas PFE's P/E ratio is 16.75. In terms of profitability, MRK's ROE is +0.38%, compared to PFE's ROE of +0.09%. Regarding short-term risk, MRK is more volatile compared to PFE. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs SNY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, SNY has a market cap of 121.2B. Regarding current trading prices, MRK is priced at $77.66, while SNY trades at $49.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas SNY's P/E ratio is 17.46. In terms of profitability, MRK's ROE is +0.38%, compared to SNY's ROE of +0.08%. Regarding short-term risk, MRK is more volatile compared to SNY. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs BMY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, BMY has a market cap of 97.4B. Regarding current trading prices, MRK is priced at $77.66, while BMY trades at $47.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas BMY's P/E ratio is 17.86. In terms of profitability, MRK's ROE is +0.38%, compared to BMY's ROE of +0.32%. Regarding short-term risk, MRK is less volatile compared to BMY. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs CELG-RI Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, CELG-RI has a market cap of 84.2B. Regarding current trading prices, MRK is priced at $77.66, while CELG-RI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to CELG-RI's ROE of +0.32%. Regarding short-term risk, MRK is more volatile compared to CELG-RI. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs GSK Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, GSK has a market cap of 83.4B. Regarding current trading prices, MRK is priced at $77.66, while GSK trades at $41.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas GSK's P/E ratio is 20.07. In terms of profitability, MRK's ROE is +0.38%, compared to GSK's ROE of +0.22%. Regarding short-term risk, MRK is more volatile compared to GSK. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs HZNP Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, MRK is priced at $77.66, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas HZNP's P/E ratio is 61.86. In terms of profitability, MRK's ROE is +0.38%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, MRK is more volatile compared to HZNP. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs BIIB Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, BIIB has a market cap of 19.1B. Regarding current trading prices, MRK is priced at $77.66, while BIIB trades at $130.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas BIIB's P/E ratio is 12.87. In terms of profitability, MRK's ROE is +0.38%, compared to BIIB's ROE of +0.09%. Regarding short-term risk, MRK is less volatile compared to BIIB. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs GRFS Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, GRFS has a market cap of 7.3B. Regarding current trading prices, MRK is priced at $77.66, while GRFS trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas GRFS's P/E ratio is 33.54. In terms of profitability, MRK's ROE is +0.38%, compared to GRFS's ROE of +0.03%. Regarding short-term risk, MRK is less volatile compared to GRFS. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs OGN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, OGN has a market cap of 2.4B. Regarding current trading prices, MRK is priced at $77.66, while OGN trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas OGN's P/E ratio is 3.19. In terms of profitability, MRK's ROE is +0.38%, compared to OGN's ROE of +1.82%. Regarding short-term risk, MRK is less volatile compared to OGN. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs CTOR Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, CTOR has a market cap of 69.5M. Regarding current trading prices, MRK is priced at $77.66, while CTOR trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas CTOR's P/E ratio is -2.56. In terms of profitability, MRK's ROE is +0.38%, compared to CTOR's ROE of -0.15%. Regarding short-term risk, MRK is less volatile compared to CTOR. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SCLX Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, SCLX has a market cap of 44.5M. Regarding current trading prices, MRK is priced at $77.66, while SCLX trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas SCLX's P/E ratio is -0.42. In terms of profitability, MRK's ROE is +0.38%, compared to SCLX's ROE of +0.36%. Regarding short-term risk, MRK is less volatile compared to SCLX. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SCLXW Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, SCLXW has a market cap of 39.5M. Regarding current trading prices, MRK is priced at $77.66, while SCLXW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas SCLXW's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to SCLXW's ROE of +0.36%. Regarding short-term risk, MRK is less volatile compared to SCLXW. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs MIRA Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, MIRA has a market cap of 23.9M. Regarding current trading prices, MRK is priced at $77.66, while MIRA trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas MIRA's P/E ratio is -3.00. In terms of profitability, MRK's ROE is +0.38%, compared to MIRA's ROE of -3.41%. Regarding short-term risk, MRK is less volatile compared to MIRA. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SRXH Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, SRXH has a market cap of 7.4M. Regarding current trading prices, MRK is priced at $77.66, while SRXH trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas SRXH's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to SRXH's ROE of -0.50%. Regarding short-term risk, MRK is less volatile compared to SRXH. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs CRXT Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 195B. In comparison, CRXT has a market cap of 0. Regarding current trading prices, MRK is priced at $77.66, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.29, whereas CRXT's P/E ratio is -0.02. In terms of profitability, MRK's ROE is +0.38%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, MRK is less volatile compared to CRXT. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.